Immune Hemolytic Anemias Flashcards
immune hemolytic anemia
shortening of RBC survival due to antibodies coating the red cells
anemia of increased destruction
Immune Hemolytic Anemias requiring transfusion support (3 categories)
- Alloimmune hemolytic anemia
- Autoimmune hemolytic anemia
- Drug-induced hemolytic anemia
Lab indicators of immune hemolysis
positive DAT increased retics increased LDH-intravascular hemolysis increased indirect bilirubin decreased hemoglobin & hematocrit decreased haptoglobin spherocytes -extravascular
Intravascular hemolysis
increased bilirubin
hemoglobinuria, hemoglobinemia
positive DAT
schistocytes
Extravascular hemolysis
increased bilirubin
no hemoglobinuria, no hemoglobinemia
positive DAT
spherocytes
Extravascular targeting of Coated RBCs
A. reticular endothelial system (RES) can ‘pluck’ IgG-coated RBCs & create spherocytes
B. RES can engulf & phagocytize RBCs IgG-coated RBCs in the spleen
C. RES can remove IgG & Complement coated RBCs in the liver
Direct Antiglobulin Test
detect IgG &/or complement attached to the red cell surface
up to 90 molecules of IgG may be present normally
threshold for positive DAT
100-500 molecules of IgG
400-1100 molecules of C3d
reasons for positive DAT besides the obvious
0.3-1.0% of hospitalized pts will have a positive DAT w/o clinical hemolysis
IVIG!!!
recent transfusion
drug associated w/ immune hemolytic anemias
organ transplant
septicemia-bc of constant complement activation
DAT tips for accuracy
RBCs must be washed thoroughly = false negative
RBCs must be tested immediately after washing to avoid false negatives
used EDTA sample to avoid false positive
Additional testing when autoantibodies are present
- elution when DAT IgG is positive
2. absorption: remove warm/cold autoantibody
Autoantibodies general
must resolve cold autos in order to ABO type
must resolve warm autos in order to screen for alloantibodies
serologic findings DO NOT always imply hemolytic anemias
clinical significance varies
how to predict if autoantibodies are clinically significant
thermal range - high range cold autos & warm autos
ability of antibody to fix complement
titer of antibody bound to RBCs
underlying disease
Cold Autoagglutinin Disease
hemolytic anemia associated w/ autoantibodies reacting in the cold
18% of all AIHAs
acute & chronic
Acute CAD
usually fairly mild anemia
anti-I: can happen in mycoplasma pneumonia & other bacterial infections
anti-i: CMV, infectious mononucleosis etc
usually do not require any transfusion support
chronic CAD
most serious clinically
more common in the elderly, lymphoma, chronoic lymphocytic leukemia
most severe cases in younger individuals w/ no known underlying cause